- PodcastOne Repays $1 Million of Its Debt Convertible at $3 and Expects to Repay an Additional $1 Million to $2 Million - Extends Record Date to April 20, 2023 - Increases Dividend of PodcastOne Shares to LiveOne’s Shareholders of Record to Between 12% and 16% - LiveOne’s Buyback Exceeds… Read More..

PRINCETON, N.J., April 5, 2023 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that the United States Adopted Names (USAN) Council has approved the use… Read More..

Lipella awarded $1.35m grant in 2022 for development of intravesical contrast-enhanced magnetic resonance imaging (ICE-MRI) technology. PITTSBURGH, April 5, 2023 /PRNewswire/ -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) ("Lipella" or the "Company"), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announces it has dosed the first patient… Read More..